MSPEA makes another partial exit from Sihuan Pharma
Morgan Stanley Private Equity Asia (MSPEA) has made another partial exit from Hong Kong-listed Sihuan Pharmaceuticals, generating up to HK$1.12 billion ($145 million) through a block trade.
The PE firm, which supported management in a privatization of Singapore-listed Sihuan in 2009 before re-listing the business in Hong Kong the following year, sold 120 million shares at HK$9.36 apiece....
More on Exits
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.